Home › Atrial Fibrillation › NCT05111015

Tracking Results of Ablations to Combat AF Registry Generation 2

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s)
2. Patient is willing to provide informed consent
3. Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria:

1\. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.

About the study

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

What is being tested

• Open Concomitant Surgical Ablation Procedures (device)
• Hybrid (Convergent) Ablation Procedures (device)
• AtriCure Hybrid Totally Thoracoscopic Ablation Procedures (device)
• AtriCure LAA Exclusion Procedures (device)

Sponsor: AtriCure, Inc. · Participants: 10,000 · Started: Mar 11, 2024

Contact the study team

• Jarrod Goodarz, BA · Phone: 609-331-6621
• Joey Stimler, DPT · Phone: 513-926-3875

Official record on ClinicalTrials.gov — NCT05111015

Locations in the U.S.

Conditions

• Atrial Fibrillation

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.